LY3113593
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY3113593, covering 2019-01-22 to 2019-03-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3113593 in Participants With Chronic Kidney Disease [Phase 1]